Acetyl-CoA acyltransferase (ACAA) was shown to have a negative correlation with the resistance of the targeted cancer drug, cetuximab, in CRC which the overexpression of ACAA would suppress proliferation and lower cetuximab tolerance in CRC cells [110]. Here, ACAA1 is linked to cancer.